Similar articles

• Correction of brain oligodendrocytes by AAVrh.10 intracerebral gene therapy in metachromatic leukodystrophy mice.

  Piguet F, Sondhi D, Piraud M, Fouquet F, Hackett NR, Ahouansou O, Vanier MT, Bieche I, Aubourg P, Crystal RG, Cartier N, Sevin C. Piguet F, et al. Hum Gene Ther. 2012 Aug;23(8):903-14. doi: 10.1089/hum.2012.015. Epub 2012 Jul 23. Hum Gene Ther. 2012. PMID: 22642214 Free PMC article.
• AAV1 mediated co-expression of formylglycine-generating enzyme and arylsulfatase a efficiently corrects sulfatide storage in a mouse model of metachromatic leukodystrophy.

  Kurai T, Hisayasu S, Kitagawa R, Migita M, Suzuki H, Hirai Y, Shimada T. Kurai T, et al. Mol Ther. 2007 Jan;15(1):38-43. doi: 10.1038/sj.mt.6300012. Mol Ther. 2007. PMID: 17164773
• Metachromatic leukodystrophy and transplantation: remyelination, no cross-correction.

  Wolf NI, Breur M, Plug B, Beerepoot S, Westerveld ASR, van Rappard DF, de Vries SI, Kole MHP, Vanderver A, van der Knaap MS, Lindemans CA, van Hasselt PM, Boelens JJ, Matzner U, Gieselmann V, Bugiani M. Wolf NI, et al. Ann Clin Transl Neurol. 2020 Feb;7(2):169-180. doi: 10.1002/acn3.50975. Epub 2020 Jan 22. Ann Clin Transl Neurol. 2020. PMID: 31967741 Free PMC article.
• Novel candidate disease for gene therapy: metachromatic leukodystrophy.

  Biffi A, Naldini L. Biffi A, et al. Expert Opin Biol Ther. 2007 Aug;7(8):1193-205. doi: 10.1517/14712598.7.8.1193. Expert Opin Biol Ther. 2007. PMID: 17696818 Review.
• Metachromatic leukodystrophy: recent research developments.

  Gieselmann V. Gieselmann V. J Child Neurol. 2003 Sep;18(9):591-4. doi: 10.1177/08830738030180090301. J Child Neurol. 2003. PMID: 14572136 Review.